Healthcare provider profile · identity verified

Ichha Sethi, MD

Family Practice · SPRINGFIELD, MO · NPI 1588911580

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	637	169
Gabapentin	Gabapentin	435	91
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	391	61
Montelukast Sodium	Montelukast Sodium	390	99
Levothyroxine Sodium	Levothyroxine Sodium	375	91
Lisinopril	Lisinopril	372	91
Pantoprazole Sodium	Pantoprazole Sodium	342	77
Albuterol Sulfate Hfa	Albuterol Sulfate	325	87
Amlodipine Besylate	Amlodipine Besylate	323	87
Alprazolam	Alprazolam	307	50
Tizanidine Hcl	Tizanidine Hcl	306	86
Trazodone Hcl	Trazodone Hcl	252	60
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	215	28
Losartan Potassium	Losartan Potassium	214	60
Omeprazole	Omeprazole	214	50
Metformin Hcl	Metformin Hcl	201	49
Buspirone Hcl	Buspirone Hcl	198	37
Meloxicam	Meloxicam	197	51
Tramadol Hcl	Tramadol Hcl	193	39
Bupropion Xl	Bupropion Hcl	188	44
Metoprolol Succinate	Metoprolol Succinate	187	48
Venlafaxine Hcl Er	Venlafaxine Hcl	184	24
Glimepiride	Glimepiride	177	44
Fluticasone Propionate	Fluticasone Propionate	171	47
Pregabalin	Pregabalin	166	25
Furosemide	Furosemide	164	43
Hydrochlorothiazide	Hydrochlorothiazide	161	50
Fluoxetine Hcl	Fluoxetine Hcl	157	45
Famotidine	Famotidine	145	35
Rosuvastatin Calcium	Rosuvastatin Calcium	145	31
Potassium Chloride	Potassium Chloride	130	26
Duloxetine Hcl	Duloxetine Hcl	115	23
Oxybutynin Chloride Er	Oxybutynin Chloride	113	31
Baclofen	Baclofen	110	24
Hydroxyzine Hcl	Hydroxyzine Hcl	109	30
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	104	19
Citalopram Hbr	Citalopram Hydrobromide	102	27
Zolpidem Tartrate	Zolpidem Tartrate	100	16
Sertraline Hcl	Sertraline Hcl	93	28
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	92	31
Tamsulosin Hcl	Tamsulosin Hcl	88	19
Metoprolol Tartrate	Metoprolol Tartrate	84	21
Warfarin Sodium	Warfarin Sodium	84	14
Carvedilol	Carvedilol	83	18
Lovastatin	Lovastatin	82	20
Amitriptyline Hcl	Amitriptyline Hcl	80	23
Clonazepam	Clonazepam	79	13
Ropinirole Hcl	Ropinirole Hcl	78	16
Simvastatin	Simvastatin	78	24
Ozempic	Semaglutide	75	14
Alendronate Sodium	Alendronate Sodium	73	19
Eliquis	Apixaban	73	13
Pravastatin Sodium	Pravastatin Sodium	73	24
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	70	12
Ondansetron Odt	Ondansetron	69	25
Quetiapine Fumarate	Quetiapine Fumarate	69	12
Lorazepam	Lorazepam	68	12
Allopurinol	Allopurinol	67	17
Metformin Hcl Er	Metformin Hcl	67	24
Dicyclomine Hcl	Dicyclomine Hcl	65	19
Azelastine Hcl	Azelastine Hcl	61	27
Clopidogrel	Clopidogrel Bisulfate	60	17
Topiramate	Topiramate	60	12
Rizatriptan	Rizatriptan Benzoate	59	12
Mounjaro	Tirzepatide	58	15
Paliperidone Er	Paliperidone	56	suppressed
Jardiance	Empagliflozin	55	18
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	55	11
Sumatriptan Succinate	Sumatriptan Succinate	54	11
Oxycodone Hcl	Oxycodone Hcl	53	suppressed
Mirtazapine	Mirtazapine	51	13
Symbicort	Budesonide/Formoterol Fumarate	51	17
Aripiprazole	Aripiprazole	50	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	50	suppressed
Januvia	Sitagliptin Phosphate	50	14
Methocarbamol	Methocarbamol	49	14
Varenicline Tartrate	Varenicline Tartrate	49	suppressed
Clonidine Hcl	Clonidine Hcl	47	13
Hydralazine Hcl	Hydralazine Hcl	47	suppressed
Propranolol Hcl	Propranolol Hcl	46	11
Triamcinolone Acetonide	Triamcinolone Acetonide	46	20
Bupropion Hcl Sr	Bupropion Hcl	44	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	44	suppressed
Carisoprodol	Carisoprodol	43	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	43	11
Diclofenac Sodium	Diclofenac Sodium	42	14
Glipizide	Glipizide	42	suppressed
Prenatal Vitamin Plus Low Iron	Pnv,calcium 72/Iron/Folic Acid	41	suppressed
Donepezil Hcl	Donepezil Hcl	40	12
Gemfibrozil	Gemfibrozil	36	suppressed
Meclizine Hcl	Meclizine Hcl	36	suppressed
Atenolol	Atenolol	35	12
Doxycycline Hyclate	Doxycycline Hyclate	35	13
Ezetimibe	Ezetimibe	35	suppressed
Fenofibrate	Fenofibrate	35	suppressed
Prednisone	Prednisone	35	17
Ibuprofen	Ibuprofen	34	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	34	suppressed
Valacyclovir	Valacyclovir Hcl	34	15
Azithromycin	Azithromycin	33	29
Bumetanide	Bumetanide	33	suppressed
Promethazine Hcl	Promethazine Hcl	33	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	32	12
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	32	suppressed
Spironolactone	Spironolactone	30	13
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	28	26
Solifenacin Succinate	Solifenacin Succinate	28	suppressed
Levetiracetam	Levetiracetam	27	suppressed
Prazosin Hcl	Prazosin Hcl	27	suppressed
Abrysvo	Rsv Vacc, Pref A And Pref B/Pf	26	26
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	26	suppressed
Finasteride	Finasteride	26	suppressed
Fluconazole	Fluconazole	26	11
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	25	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	23	suppressed
Nystatin	Nystatin	23	suppressed
Breo Ellipta	Fluticasone/Vilanterol	22	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	22	suppressed
Farxiga	Dapagliflozin Propanediol	21	suppressed
Lamotrigine	Lamotrigine	21	suppressed
Myrbetriq	Mirabegron	21	suppressed
Ropinirole Er	Ropinirole Hcl	21	suppressed
Ventolin Hfa	Albuterol Sulfate	21	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	20	suppressed
Nitroglycerin	Nitroglycerin	20	15
Olmesartan Medoxomil	Olmesartan Medoxomil	20	suppressed
Paroxetine Hcl	Paroxetine Hcl	20	suppressed
Spiriva Respimat	Tiotropium Bromide	20	suppressed
Ondansetron Hcl	Ondansetron Hcl	19	suppressed
Estradiol	Estradiol	18	suppressed
Loperamide	Loperamide Hcl	18	suppressed
Celecoxib	Celecoxib	17	suppressed
Enalapril Maleate	Enalapril Maleate	17	suppressed
Fenofibrate	Fenofibrate,micronized	17	suppressed
Incruse Ellipta	Umeclidinium Bromide	16	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	16	suppressed
Naproxen	Naproxen	16	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	16	suppressed
Clobetasol Propionate	Clobetasol Propionate	15	suppressed
Diazepam	Diazepam	15	suppressed
Novolog Flexpen	Insulin Aspart	15	suppressed
Oxcarbazepine	Oxcarbazepine	15	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	15	suppressed
Atomoxetine Hcl	Atomoxetine Hcl	14	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	14	suppressed
Hydromorphone Hcl	Hydromorphone Hcl	14	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	14	suppressed
Terazosin Hcl	Terazosin Hcl	14	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	14	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	14	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	13	suppressed
Levemir Flexpen	Insulin Detemir	13	suppressed
Nifedipine Er	Nifedipine	13	suppressed
Bicalutamide	Bicalutamide	12	suppressed
Carbamazepine	Carbamazepine	12	suppressed
Mometasone Furoate	Mometasone Furoate	12	suppressed
Doxepin Hcl	Doxepin Hcl	11	suppressed
Euthyrox	Levothyroxine Sodium	11	suppressed
Klor-Con M20	Potassium Chloride	11	suppressed
Linzess	Linaclotide	11	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	11	suppressed
Repaglinide	Repaglinide	11	suppressed
Xarelto	Rivaroxaban	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error